Dual-Purpose Imaging Agent Tracks Molecules Inside Living Bodies

AI Insight

Researchers developed a single europium-based molecular complex that can switch between Eu2+ and Eu3+ oxidation states, enabling dual-mode imaging through both optical luminescence and magnetic resonance. This platform allows for simultaneous or sequential optical and MRI imaging in living organisms using a single contrast agent, rather than requiring separate molecules for each imaging modality. The switchable oxidation states provide distinct magnetic and luminescent properties that can be controlled chemically.

Why it matters

This technology could improve medical diagnostics by enabling more comprehensive imaging with a single injection, reducing patient exposure to multiple contrast agents and allowing better correlation between different imaging techniques. The dual-functionality approach represents a significant advance in multimodal molecular imaging for potential clinical applications.